Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

Bibliographic Details
Main Authors:	Salugina, SO, Fedorov, ES, Alexandrova, EN, Novikov, AA, Cherkasova, MV, Baranov, AA, Valogina, YA, Nikolaeva, TN, Zubova, NA
Format:	Online
Language:	English
Published:	BioMed Central 2008
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334154/

Similar Items

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
by: Gonzalez-Lopez, Laura, et al.
Published: (2014)

The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients
by: Lamot, L, et al.
Published: (2008)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
by: Guseinova, D, et al.
Published: (2008)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
by: Avdeeva, A. S., et al.
Published: (2014)

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis
by: Gilliam, Brooke E, et al.
Published: (2013)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
by: Dejaco, Christian, et al.
Published: (2006)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
by: Vossenaar, Erik R, et al.
Published: (2004)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
by: Van Steendam, Katleen, et al.
Published: (2011)

Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
by: Salugina, SO, et al.
Published: (2011)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
by: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Published: (2011)

Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma
by: Hampras, Shalaka S., et al.
Published: (2015)

The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children
by: Kostik, MM, et al.
Published: (2008)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
by: Al-Shukaili, Ahmed, et al.
Published: (2012)

No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer
by: Khan, G, et al.
Published: (2012)

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
by: Dalmády, Szandra, et al.
Published: (2013)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
by: Lindenberg, Luisa, et al.
Published: (2015)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
by: Safi, Mohammad-Ayman A., et al.
Published: (2015)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo, Anne E, et al.
Published: (2012)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Mohamed Hamooda, et al.
Published: (2016-09-01)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Hamooda, Mohamed, et al.
Published: (2016)

Confirmation of the validity of using birth MCV for the diagnosis of alpha thalassemia trait
by: Al-Hilali, Akram M., et al.
Published: (2009)

Cryptanalysis of Low-Data Instances of Full LowMCv2
by: Christian Rechberger, et al.
Published: (2018-09-01)

Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity
by: Brentville, Victoria A., et al.
Published: (2016)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
by: Abdeen, Suad, et al.
Published: (2011)

Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort
by: Degboé, Yannick, et al.
Published: (2015)

PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
by: Zholobova, ES, et al.
Published: (2013)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
by: Zholobova, ES, et al.
Published: (2013)

Indirect comparison of etanercept and abatacept efficacy and safety in patients with polyarticular juvenile idiopathic arthritis
by: Loskutova (Konopelko), OU, et al.
Published: (2014)

Comparative characteristic of quality of life with patients suffering from juvenile idiopathic arthritis (JIA), attending school and taught at home
by: Shelepina, TA, et al.
Published: (2011)

Tolerogenic citrullinated peptide for arthritis
by: Gertel, Smadar, et al.
Published: (2015)

Description Kelley-Seegmiller syndrome (partial HPRT deficiency manifesting as a gout-urolithiasis syndrome) in a patient of 15 years old
by: Rodionovskaya, SR, et al.
Published: (2011)

P02-012 - HAIDS in practice of Russian rheumatologist
by: Fedorov, E, et al.
Published: (2013)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
by: Díaz-Toscano, Miriam Lizette, et al.
Published: (2014)

PReS-FINAL-2241: Cases of cryopyrin-associated periodic syndromes (CAPS) in one single rheumatologic center of Russia
by: Salugina, SO, et al.
Published: (2013)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
by: Arsenyeva, Svetlana V, et al.
Published: (2014)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
by: Pruijn, Ger J. M.
Published: (2015)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
by: Bo, Li, et al.
Published: (2008)

Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis
by: Mistry, BJ, et al.
Published: (2008)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
by: Vavrinec, J, et al.
Published: (2002)

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
by: Gilliam, Brooke E, et al.
Published: (2011)